Mary Beth Schornak

Mary Beth Schornak

Director of Finance

Mary Beth Schornak is the Finance Director at Bitterroot. She has over 15 years of experience in finance and accounting, specifically supporting life sciences companies. Before joining Bitterroot, she served as Controller in a director-level position at Faraday Pharmaceuticals, where she led accounting for a global Phase 3 clinical trial, oversaw financial reporting, and managed accounting operations for both U.S. and Australian entities.

Prior to Faraday, Mary Beth provided Controller services to various life sciences companies as an independent consultant. Mary Beth received a B.A. in Business Administration from the University of Puget Sound and is a Certified Public Accountant in Washington State (inactive).

Bitterroot Bio is a privately held company dedicated to the pursuit of breakthroughs in cardiovascular medicine. We are committed to improving the lives of patients, and we believe that focusing on research and development is the best way to achieve that goal. We do not engage in, support, or advocate on behalf of political, social, environmental, or other causes that are unrelated to our mission.
Scroll to Top